Oaktree Capital Management »

Neogenomics shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Neogenomics shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Neogenomics

Tip: Access up to 7 years of quarterly data

All positions including Neogenomics held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neogenomics by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.0M 3.6M 0.83
2024-03-31 $2.4M 2.9M 0.80
2023-12-31 $2.8M 3.6M 0.77
2023-09-30 $4.4M 6.1M 0.72
2023-06-30 $9.1M 12M 0.74
2023-03-31 $9.0M 12M 0.74
2022-12-31 $3.8M 5.8M 0.66
2022-09-30 $959k 1.5M 0.65
2022-03-31 $535k 817k 0.65
2021-03-31 $3.3M 3.3M 1.01

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Chesapeake Energy Corp Common Stock (CHK)
Garrett Motion Common Stock (GTX)
Sitio Royalties Corp Common Stock (STR)
State Street Corp Etf Put Option (SPY)
Infinera Corp Common Stock (INFN)
Anglogold Ashanti Common Stock (AU)
Liberty Global Common Stock Call Option (LBTYA)
Star Bulk Carriers Corp Common Stock (SBLK)
Sunopta Common Stock (STKL)
Talen Energy Corp Common Stock (TLN)
Freeport-mcmoran Common Stock (FCX)
Runway Growth Finance Corp Common Stock (RWAY)
Vista Energy Sab De Cv Common Stock (VIST)
California Resources Corp Common Stock (CRC)

View all positions for Oaktree Capital Management

Top funds holding Neogenomics

Braidwell
Calamos Advisors
Tenor Capital Management
Advent Capital Management
Goldman Sachs Group
Silverback Asset Management
Capstone Investment Advisors
New York State Common Retirement Fund
Oaktree Capital Management
Wolverine Asset Management
BlackRock
BlackRock
Deutsche Bank Aktiengesellschaft
Russell Investments
CSS

View all funds holding Neogenomics